Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN140,06140,10,21
Msft-1,34
Nokia10,8211,1153,27
IBM-0,67
Mercedes-Benz Group AG50,1350,06-0,38
PFE-3,02
09.05.2026 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 07.05.2026
Hafnia Ltd Rg (Oslo)
Závěr k 7.5.2026 Změna (%) Změna (NOK) Objem obchodů (NOK)
80,25 -1,77 -1,45 -
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 10.05.2026
Popis společnosti

Business Summary: Hafnia Limited is a tanker company. The principal activity of the Company is investment holding. The Company’s segments include Long Range II (LR2), Long Range I (LR1), Medium Range (MR), Handy, and Specialised. The LR2 segment consists of vessels between 85,000 deadweight tons (DWT) and 124,999 DWT in size and provides transportation of clean petroleum oil products. The LR1 segment consists of vessels between 55,000 DWT and 84,999 DWT in size and provides transportation of clean and dirty petroleum products. The MR segment consists of vessels between 40,000 DWT and 54,999 DWT in size. The Handy segment consists of vessels between 25,000 DWT and 39,999 DWT in size and provides transportation of clean and dirty oil products, vegetable oil, and easy chemicals. The Specialised segment consists of vessels between 5,000 DWT and 19,999 DWT in size. Its subsidiaries include Hafnia Pte. Ltd., Hafnia Tankers Marshall Islands LLC, Hafnia Holding Limited, and Hafnia Holding II Limited.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, Hafnia Ltd revenues decreased 20% to $2.28B. Net income decreased 56% to $339.7M. Revenues reflect LR1 segment decrease of 28% to $604.4M, MR segment decrease of 15% to $1.15B. Net income also reflects Gain on disposal of assets decrease of 57% to $12.2M (income), General and administrative expenses - Ba increase of 7% to $84.9M (expense). Dividend per share decreased from $1.16 to $0.55.



  • Poslední aktualizace: 10.05.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive Officer, Executive DirectorDeepak Nath-01.04.202201.04.2022
Chief Financial Officer, Executive DirectorJohn Rogers-01.04.202401.12.2023
President - Global OperationsPaul Connolly-
President - OrthopaedicsCraig Gaffin-04.03.202404.03.2024
President - Advanced Wound Management and Global Commercial OperationsRohit Kashyap5501.01.2023
President - Research & Development, ENT and Emerging MarketsVasant Padmanabhan-
President - Sports MedicineScott Schaffner5601.01.2023
Chief Human Resources OfficerElga Lohler-
Chief Compliance OfficerAlison Parkes-
Group General Counsel, Company SecretaryHelen Barraclough47